The TEX47 antibody specifically binds to amino acids 1–253 of the human TEX47 protein (UniProt ID: Q8TBZ9) . This protein is predominantly expressed in testicular tissue but has also been studied in cancer research due to its differential expression patterns . The antibody is produced in rabbits and conjugated with biotin for enhanced detection in assays like ELISA .
The Human Protein Atlas provides critical insights into TEX47 expression across cancers :
| Cancer Type | RNA Expression Category | Expression Level |
|---|---|---|
| Testicular Cancer | Tissue Enriched | High |
| Bladder Cancer | Low Tissue Specificity | Moderate |
| Breast Cancer | Not Detected | Low/None |
| Colorectal Cancer | Low Tissue Specificity | Moderate |
| Lung Cancer | Not Detected | Low/None |
High Expression: Observed in testicular tissues and some germ cell tumors.
Low/No Expression: Detected in bladder, colorectal, and prostate cancers, though at levels below clinical significance .
Diagnostic Potential: While TEX47 is not a primary biomarker for common cancers like bladder or breast cancer, its testis-enriched expression suggests utility in studying germ cell malignancies .
Experimental Use: The biotin-conjugated TEX47 antibody enables sensitive detection in ELISA and WB, facilitating studies on protein localization and interaction networks .
TEX47, also known as dynein-associated BLUF protein or uncharacterized protein C7orf62, is a 253 amino acid protein with a molecular mass of approximately 29.5 kDa that shows testis-specific expression in humans . Its importance in research stems from its putative role as a human orthologue of LAX28, a protein required for the stable assembly of the inner dynein arm f complex in flagella . This connection suggests TEX47 may play a critical role in human sperm motility and potentially in other ciliated cells. Understanding TEX47 function could provide insights into certain forms of male infertility and ciliopathies.
Based on current commercial offerings, TEX47 antibodies are validated for multiple research applications including Western Blotting (WB), immunohistochemistry on frozen sections (IHC-fr), immunohistochemistry on paraffin-embedded tissues (IHC-p), and immunofluorescence (IF) . The availability of differently conjugated antibodies (such as biotin-tagged and Cy5-tagged options) expands the potential applications to include multiplexed detection systems and flow cytometry, though researchers should verify specific validations for their experimental systems.
TEX47 exhibits highly specific expression primarily in testicular tissue . This tissue-restricted pattern makes it particularly valuable for reproductive biology research and as a potential biomarker for testis-specific processes. When designing experiments to study TEX47, researchers should consider using testicular tissue as positive controls and non-reproductive tissues as negative controls to verify antibody specificity.
Antibody validation should include:
Western blot analysis showing a band at the expected molecular weight (29.5 kDa)
Comparison of staining between testicular tissue (positive) and non-expressing tissues (negative)
Knockdown or knockout controls if available
Peptide competition assays to verify epitope specificity
Testing multiple antibody clones targeting different epitopes of TEX47
This multi-approach validation strategy helps ensure experimental results reflect true TEX47 biology rather than non-specific binding artifacts.
TEX47 shares structural features with sensory BLUF (Blue Light Using FAD) domain-containing proteins , suggesting potential roles in signaling or protein-protein interactions. Research in Leishmania has shown that LAX28 (the TEX47 orthologue) is essential for stable assembly of the inner dynein arm f complex and proper flagellar function . TEX47 likely serves as a structural component that bridges or stabilizes interactions between dynein complex subunits.
Current structural analysis suggests the BLUF domain may function in protein-protein interactions rather than in blue light sensing in this context. Researchers investigating TEX47 function should consider protein-protein interaction studies (co-immunoprecipitation, proximity labeling) to identify binding partners within the dynein complex.
When studying TEX47 in human sperm samples, researchers should consider:
Sample preparation: Fresh samples should be processed promptly to preserve protein integrity
Fixation protocols: Optimized paraformaldehyde fixation (typically 4%) is recommended for immunofluorescence studies
Permeabilization: Due to the compact nature of sperm chromatin, enhanced permeabilization may be necessary (0.5% Triton X-100)
Antibody selection: Use antibodies validated specifically for sperm immunocytochemistry
Controls: Include healthy donor samples as positive controls and pre-immune serum as negative controls
For Western blotting applications, specialized sperm protein extraction buffers containing reducing agents and protease inhibitors are essential to overcome the highly crosslinked nature of sperm proteins.
Given the connection between TEX47 and flagellar/ciliary dynein complexes , TEX47 antibodies can be valuable tools for investigating ciliopathies through:
Immunohistochemical analysis of ciliated tissues from patients with suspected ciliopathies
Co-localization studies with other ciliary markers to assess ciliary structure integrity
Comparative analysis of TEX47 localization in healthy versus diseased ciliated tissues
Quantitative assessment of TEX47 expression levels in patient samples
Screening for TEX47 interactions with known ciliopathy-associated proteins
Researchers should employ both tissue and cell culture models of ciliopathies, utilizing TEX47 antibodies to examine potential contributions to disease mechanisms.
When facing conflicting results in TEX47 immunodetection:
Compare antibody epitopes: Different antibodies may target distinct regions of TEX47, potentially recognizing different isoforms or post-translationally modified variants
Evaluate fixation sensitivity: Test multiple fixation protocols as some epitopes may be fixative-sensitive
Implement orthogonal detection methods: Combine antibody-based detection with mRNA analysis or mass spectrometry
Consider species differences: If using model organisms, sequence homology and conservation of the epitope region should be verified
Examine expression conditions: TEX47 expression may be developmentally regulated or influenced by physiological state
A systematic comparison table documenting experimental conditions across studies can help identify sources of variation leading to contradictory results.
For optimal Western blot detection of TEX47:
Sample preparation: Use strong lysis buffers (containing SDS and reducing agents) to ensure complete protein extraction
Gel percentage: 12-15% polyacrylamide gels provide optimal resolution for the 29.5 kDa TEX47 protein
Transfer conditions: Semi-dry or wet transfer at 100V for 1 hour typically yields efficient transfer
Blocking: 5% non-fat milk or BSA in TBST for 1 hour at room temperature
Primary antibody dilution: Typically 1:1000, but optimization is recommended for each antibody
Incubation: Overnight at 4°C provides the best signal-to-noise ratio
Detection system: HRP-conjugated secondary antibodies with enhanced chemiluminescence detection offer good sensitivity
These conditions should be optimized for specific experimental systems, as protein extraction efficiency can vary between tissue types.
For optimal co-localization studies with TEX47 antibodies:
Use TEX47 antibodies with different host species than antibodies for co-localization targets
For multi-color imaging, select conjugated TEX47 antibodies (such as Cy5-conjugated options ) compatible with your fluorescence filter sets
Implement spectral unmixing if fluorophore emission spectra overlap
Employ high-resolution imaging techniques (confocal, structured illumination microscopy) for accurate co-localization assessment
Calculate co-localization coefficients (Pearson's, Mander's) for quantitative analysis
Include appropriate controls for non-specific binding and autofluorescence
Researchers should be particularly attentive to fixation protocols, as over-fixation can mask epitopes while under-fixation can result in structural artifacts.
A comprehensive experimental design would include:
Temporal analysis: Examine TEX47 expression and localization during different stages of flagellar development
Genetic manipulation: CRISPR/Cas9 knockout or knockdown of TEX47 to assess effects on flagellar structure and function
Rescue experiments: Re-expression of wild-type or mutant TEX47 in knockout models
Protein-protein interactions: Co-immunoprecipitation or proximity labeling to identify TEX47 binding partners
Functional assays: Motility analysis in sperm or other flagellated cells with modified TEX47 expression
Structural studies: Electron microscopy to assess flagellar ultrastructure in the presence/absence of TEX47
This multi-faceted approach would provide comprehensive insights into TEX47's functional role in flagellar dynamics.
TEX47 antibodies can advance male infertility research through:
Diagnostic applications: Developing immunoassays to detect TEX47 abnormalities in infertile men
Phenotypic classification: Categorizing sperm motility defects based on TEX47 expression patterns
Mechanistic studies: Investigating the molecular basis of TEX47-associated motility dysfunction
Biomarker development: Evaluating TEX47 as a potential biomarker for specific forms of male infertility
Therapeutic target assessment: Exploring TEX47-related pathways for potential therapeutic interventions
The testis-specific expression of TEX47 makes it particularly valuable for studies focused on male reproductive biology and pathology.
To investigate potential additional functions of TEX47:
Interaction proteomics: Mass spectrometry-based identification of TEX47 binding partners across different tissues
Subcellular localization studies: High-resolution imaging to determine if TEX47 localizes to structures beyond flagella
Transcriptomics analysis: RNA-seq following TEX47 manipulation to identify affected pathways
Evolutionary analysis: Comparative genomics to identify conserved domains that might suggest additional functions
Non-flagellated cell studies: Examining TEX47 expression and function in cells lacking flagella
Researchers should remain open to unexpected findings, as many proteins initially characterized in specific contexts later reveal broader biological roles.
TEX47 antibodies can complement multi-omics approaches through:
Integration with proteomics: Antibody-based enrichment for targeted mass spectrometry
Validation of transcriptomics findings: Confirming protein-level changes corresponding to TEX47 mRNA alterations
Chromatin immunoprecipitation (ChIP) studies: If TEX47 has potential nuclear functions
Tissue-specific interactome mapping: Identifying context-dependent protein interactions
Spatial transcriptomics validation: Confirming localization of TEX47 expression in complex tissues
This integration enables researchers to connect genomic, transcriptomic, and proteomic data to cellular and tissue-level observations regarding TEX47 biology.
Rigorous quality control for TEX47 antibody use should include:
Lot-to-lot validation: Comparing performance metrics between antibody lots
Multiple application testing: Confirming specificity across different experimental contexts (WB, IHC, IF)
Positive and negative control tissues: Testis tissue (positive) versus non-reproductive tissues (negative)
Peptide competition: Confirming signal abolishment when antibody is pre-incubated with immunizing peptide
Knockout validation: Testing antibody in TEX47 knockout systems when available
Cross-reactivity assessment: Testing against related proteins, particularly other BLUF domain-containing proteins
Researchers should document these validation steps in publications to enhance reproducibility and reliability of findings.
When selecting between different TEX47 antibody conjugates (e.g., biotin, Cy5) , researchers should consider:
Detection system compatibility: Ensure conjugate works with available detection instruments
Multiplexing requirements: Select conjugates that permit simultaneous detection of multiple targets
Sensitivity needs: Some conjugates offer enhanced signal amplification capabilities
Tissue autofluorescence profile: Choose fluorophores with emission spectra distinct from sample autofluorescence
Stability requirements: Consider photobleaching properties for extended imaging sessions
Application-specific optimization: Different conjugates may perform optimally in different applications
The choice should be guided by specific experimental requirements and available detection systems.